Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening.

Current oncology (Toronto, Ont.)·2025
Same author

Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides.

eLife·2025
Same author

Could immunotherapy and regulatory T cells be used therapeutically to slow the progression of Alzheimer's disease?

Brain communications·2025
Same author

Exploring the Role of Reactive Oxygen Species in the Pathogenesis and Pathophysiology of Alzheimer's and Parkinson's Disease and the Efficacy of Antioxidant Treatment.

Antioxidants (Basel, Switzerland)·2024
Same author

Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.

Molecular oncology·2024
Same author

Transformation of autophagic SQSTM1 droplets to SQSTM1-dependent P-bodies.

Autophagy·2024

Related Experiment Video

Updated: Oct 19, 2025

RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells
08:20

RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells

Published on: August 25, 2010

9.7K

Variable Dose Analysis: A Novel High-throughput RNAi Screening Method for Drosophila Cells.

Katarzyna Sierzputowska1,2,3, Chris R Baxter1,3, Benjamin E Housden1,3

  • 1Living Systems Institute, University of Exeter, Exeter, United Kingdom.

Bio-Protocol
|September 17, 2021
PubMed
Summary

Variable Dose Analysis (VDA) is a novel RNAi screening method that enhances signal-to-noise ratios. This technique reliably detects genetic interactions, even for essential genes, by analyzing phenotypes across various knockdown efficiencies.

Keywords:
S2R+ cellsDrosophilaFlow cytometryGenetic interactionsHigh-throughput screeningRNAiSynthetic lethalityViability assaydsRNAin vitro

More Related Videos

RNAi Interference by dsRNA Injection into Drosophila Embryos
08:30

RNAi Interference by dsRNA Injection into Drosophila Embryos

Published on: April 11, 2011

16.4K
A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila
06:22

A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila

Published on: March 12, 2020

6.1K

Related Experiment Videos

Last Updated: Oct 19, 2025

RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells
08:20

RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells

Published on: August 25, 2010

9.7K
RNAi Interference by dsRNA Injection into Drosophila Embryos
08:30

RNAi Interference by dsRNA Injection into Drosophila Embryos

Published on: April 11, 2011

16.4K
A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila
06:22

A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila

Published on: March 12, 2020

6.1K

Area of Science:

  • Genetics
  • Molecular Biology
  • Biotechnology

Background:

  • High-throughput genetic screens identify genes in biological processes.
  • RNAi and CRISPR are common screening technologies with distinct pros and cons.
  • Existing methods can have limitations in signal-to-noise ratio and essential gene analysis.

Purpose of the Study:

  • To introduce and validate Variable Dose Analysis (VDA) as an improved RNAi-based screening method.
  • To demonstrate VDA's capability in enhancing signal-to-noise ratio and consistency in genetic screens.
  • To enable the detection of phenotypes and genetic interactions involving essential genes.

Main Methods:

  • VDA utilizes co-transfection of cells with shRNA plasmids targeting genes of interest and reporter plasmids.
  • Fluorescent protein expression serves as an indirect readout for shRNA expression and knockdown efficiency.
  • Phenotypes are measured across a range of knockdown efficiencies within a single sample.

Main Results:

  • VDA significantly improves signal-to-noise ratio compared to previous RNAi methods.
  • VDA demonstrates enhanced consistency and reliable detection of known genetic interactions.
  • The method allows for the analysis of essential genes at sub-lethal knockdown efficiencies.

Conclusions:

  • Variable Dose Analysis is a powerful high-throughput screening approach.
  • VDA offers improved accuracy and broader applicability for genetic screens.
  • This method is valuable for investigating a wide range of biological questions, including those involving essential genes.